Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction

Harbin Medical University

Status: Unknown

Conditions: Congestive Heart Failure

Treatments: Drug: HTEA

Study type: Observational

Funder types: Other

Identifiers

NCT02292043

wei liu

Details and patient eligibility

About

The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction.

Full description

The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction. The specific index is 6 miniutes walk distance, echocardiography, NYHA, NTproBNP level, peripherial WBC, RBC, PLT, Cre, UA, K+, Na+ upon entrance to hospital and 4 weeks after HTEA treatment, and 3 months after discharge. The morbidity and re-hospitalization would also calculated 3 months after discharge.

Enrollment: 60 estimated patients

Sex: All

Ages: 20 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 90 chronic cardiac failure patients in our hospital were selected and divided into two groups.

Exclusion criteria

• Vavular diseases

Trial design

60 participants in 2 patient groups

idiopathic dilated cardiomyopathy group

Description:

idiopathic dilated cardiomyopathy group treated with HTEA

Treatment:

Drug: HTEA

post-myocardial infarction group

Description:

post-myocardial infarction group treated with TEA

Treatment:

Drug: HTEA